Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation
- 1 June 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 65 (22) , 1459-1463
- https://doi.org/10.1016/0002-9149(90)91355-a
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Dipyridamole-Thallium Scanning in Patients Undergoing Vascular SurgeryJAMA, 1987
- THE IMPACT OF DIABETES ON VASCULAR COMPLICATIONS FOLLOWING CADAVER RENAL TRANSPLANTATIONTransplantation, 1987
- Safety of intravenous dipyridamole for stress testing with thallium imagingThe American Journal of Cardiology, 1987
- Dipyridamole thallium 201 scintigraphy to detect coronary artery disease before abdominal aortic surgeryJournal of Vascular Surgery, 1987
- Evaluation of cardiovascular risk for renal transplantation in diabetic patientsThe American Journal of Medicine, 1986
- Determination of Cardiac Risk by Dipyridamole-Thallium Imaging before Peripheral Vascular SurgeryNew England Journal of Medicine, 1985
- Dipyridamole–Thallium-201 Scintigraphy in the Prediction of Future Cardiac Events after Acute Myocardial InfarctionNew England Journal of Medicine, 1984
- Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantationThe American Journal of Surgery, 1983
- Survival with Dialysis and Transplantation in Patients with End-Stage Renal DiseaseNew England Journal of Medicine, 1983
- Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trialThe American Journal of Cardiology, 1978